陽普醫療(300030.SZ):子公司醫療器械註冊證變更 增加醫用外科口罩的規格型號
格隆匯5月14日丨陽普醫療(300030.SZ)公佈,今日,公司子公司陽普醫療(湖南)有限公司(“湖南陽普”)收到了由湖南省藥品監督管理局頒發的《醫療器械註冊證》,此次變更主要增加了醫用外科口罩的規格型號,並將原註冊證的有效期從應急審批的八個月,延長至五年。
此次註冊變更增加了醫用外科口罩的型號和規格,特別是此次新增加的摺疊型頭套式口罩氣密性更好、舒適性更強,豐富了產品的品規,形成了產品系列化、差異化,增加了產品競爭力,為公司醫用外科口罩未來的持續穩定生產奠定基礎,有助於公司發揮品牌優勢,與公司醫療器械產品銷售產生協同作用,提升公司產品的核心競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.